Melanie A. Hundt
<p>Melanie A. Hundt, MD, is an attending physician at Montefiore Einstein. Dr. Hundt specializes in providing care for people with advanced liver disease, including individuals who may require a liver transplant. Dr. Hundt is passionate about increasing access to liver specialty care and transplantation.</p><p>After earning her Doctor of Medicine at the State University of New York Upstate Medical University in 2018, Dr. Hundt completed her residency at Yale New Haven Hospital in 2021. She then completed a gastroenterology fellowship and a transplant hepatology fellowship at the University of Southern California in 2024.</p><p>She has shared her work through numerous peer-reviewed publications and presentations.</p><p>Dr. Hundt is board certified in Internal Medicine. She is a member of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG) and the American Association for the Study of Liver Diseases (AASLD), among others. Dr. Hundt is fluent in English and Spanish.</p>
Joseph W. Rinaldi
Erica Chung
Christopher E. Andrade
Shivi S. Siva
Kohtaro Ooka
Advanced endoscopy: ERCP, diagnostic and therapeutic EUS, third space endoscopy<quillbot-extension-portal></quillbot-extension-portal>
Advanced endoscopy, pancreaticobiliary neoplasms, third space endoscopy.<quillbot-extension-portal></quillbot-extension-portal>
<p>Kohtaro Ooka, MD, is an attending physician in Gastroenterology. His clinical focus is advanced endoscopy, endoscopic retrograde cholangiopancreatography (ERCP), diagnostic and therapeutic endoscopic ultrasound (EUS), pancreaticobiliary diseases and third space endoscopy.</p><p>After receiving his Bachelor of Arts in economics at Pomona College, Dr. Ooka returned to the institution to complete post-baccalaureate education before pursuing his medical education. In 2010, started attending Mount Sinai School of Medicine, earning his Doctor of Medicine in 2014. He completed internship at University of Illinois Hospital in 2015, and residency at Yale School of Medicine in 2017. He continued his postgraduate training, completing a gastroenterology fellowship at University of Pittsburgh Medical Center in 2020 followed by an advanced endoscopy fellowship at NYU Langone in 2021.</p><p>Dr. Ooka’s research focuses on advanced endoscopy, pancreaticobiliary neoplasms and third space endoscopy, sharing his work through peer-reviewed journals.</p>
Harold M. Schwartz
Allan W. Wolkoff
<p><span>Dr. Allan Wolkoff's interest in research was sparked when he worked in a biochemistry lab to help pay college bills. He began his medical studies at Dartmouth Medical College and transferred to the Albert Einstein College of Medicine where he obtained his M.D. degree. With the exception of a two year period when he was Clinical Associate in Gastroenterology-Hepatology in the Digestive Disease Branch, National Institute of Arthritis, Metabolism and Digestive Disease, he has remained at Albert Einstein. His early mentor, Irwin M. Arias, M.D. of the National Institutes of Health said of Wolkoff’s work, “He built an exemplary global reputation in hepatology research, education, training and scholarship. A major participant in the creation of the Marion Bessin Liver Research Center at Albert Einstein, Dr. Wolkoff has taken advantage of the strong, interactive basic science departments and is a leader in bridging understanding of hepatocyte biology with the pathogenesis of acquired and inheritable liver diseases.” </span></p>
<p><span>Dr. Wolkoff is a pioneer in the combining of disciplines that inform basic understanding of hepatocyte function and relation to disease and is recognized worldwide for providing new windows into physiology and pathophysiology. </span><span>He has had articles published in over 100 peer-reviewed publications, given many invited lectures and has had continuous NIH-supported research. In addition, he has served on advisory committees of several NIH-supported liver research centers. In 2006, he was presented the AASLD Distinguished Service Award. In 2012, he received the <span>highly prestigious 2012 Distinguished Scientific Achievement Award from the American Liver Foundation.</span></span></p>
Diseases of the liver and biliary tract including chronic liver disease, fatty liver disease, hepatitis, inheritable disorders of the liver, drug toxicity, and unexplained jaundice.<quillbot-extension-portal></quillbot-extension-portal>
Research interests include the mechanism by which the liver removes drugs and other compounds from the circulation and how its dysfunction may lead to drug toxicity.<quillbot-extension-portal></quillbot-extension-portal>
<p>Allan W. Wolkoff, MD, is Chief, Hepatology, Herman Lopata Chair in Liver Disease Research and Professor, Medicine and Developmental & Molecular Biology at Montefiore Einstein. His clinical focus centers on diseases of the liver and biliary tract, including chronic liver disease, fatty liver disease, hepatitis, inheritable disorders of the liver, drug toxicity and unexplained jaundice.</p><p>Dr. Wolkoff began his medical studies at Dartmouth Medical College and transferred to Einstein, where he earned his Doctor of Medicine in 1972. He completed an internship at Bronx Municipal Hospital Center in 1973 before becoming an Assistant Resident in Medicine until 1974. Following this, Dr. Wolkoff became a Clinical Associate in Gastroenterology-Hepatology at the National Institutes of Health (NIH) until 1976.</p><p>A pioneer in combining disciplines that inform basic understanding of hepatocyte function and relation to disease, Dr. Wolkoff is recognized worldwide for providing new windows into physiology and pathophysiology. His research interests include the mechanism by which the liver removes drugs and other compounds from circulation and how its dysfunction may lead to drug toxicity. He has had articles published in over 100 peer-reviewed publications, given many invited lectures and has had continuous NIH-supported research.</p><p>Dr. Wolkoff has served on advisory committees of several NIH-supported liver research centers. In 2006, he was presented with the American Association for the Study of Liver Diseases (AASLD) Distinguished Service Award. In 2012, he received the highly prestigious Distinguished Scientific Achievement Award from the American Liver Foundation. He was named Physician of the Year by the Greater New York Division of the American Liver Foundation in 2015 and won the National Leadership Award from the American Liver Foundation in 2022.</p>
Francis R. Weiner
Liver disease, all types of viral hepatitis, and NAFLD(fatty liver)<br /><quillbot-extension-portal></quillbot-extension-portal>
Pathogenesis of liver fibrosis
<p>Francis Weiner, MD, is an attending physician and Assistant Professor, Medicine at Montefiore Einstein. His clinical focus centers on liver disease, all types of viral hepatitis and nonalcoholic fatty liver disease (NAFLD).</p><p>After earning his Doctor of Medicine at Mount Sinai School of Medicine in 1979, Dr. Weiner completed his medical internship at Vermont Medical Center in 1980. He remained at this institution as a junior medical resident until 1981 before moving on to become a senior medical resident until 1982. Dr. Weiner then came to Einstein to complete a research hepatology fellowship in 1985 and a clinical gastroenterology and hepatology fellowship in 1986. He was Senior Research Hepatology Fellow in his final year.</p><p>Building on his clinical focus, Dr. Weiner has researched natural alpha interferon in the treatment of naive patients with chronic Hepatitis C, natural alpha interferon for the treatment of relapsers and nonresponders with chronic Hepatitis C and Rebetron for the treatment of nonresponders and relapsers with chronic Hepatitis C. His work has been published in numerous peer-reviewed journals, abstracts and book chapters.</p><p>Dr. Weiner is board certified in Gastroenterology and is a diplomat of the American Board of Internal Medicine and the National Board of Medical Examiners. He is a fellow of the American College of Gastroenterology and a member of the American Gastroenterological Association and the American Association for the Study of Liver Disease. Dr. Weiner received the American Liver Foundation Fellowship Award in 1984 and 1985, as well as the National Institutes of Health (NIH) National Research Service Award in 1985.</p>